Skip to main content

Table 1 List of gene targets selected for TaqMan® validation in cohort 1

From: An integrative model for recurrence in ovarian cancer

Gene Symbol

Probe ID

P value

Array fold change

Expression in recurrent vs primary

Assay ID

CLDN16

163630

0.0068

9

Upregulated

Hs00198134_m1

S100B

114188

0.0001

6.12

Upregulated

Hs00389217_m1

CACNAID

127127

0.00012

3.9

Upregulated

Hs00167753_m1

BTC

112710

0.0006

2.67

Upregulated

Hs00156140_m1

IL27RA

145754

0.0005

1.82

Upregulated

Hs00175472_m1

CHORDC1

183675

0.0002

1.359

Upregulated

Hs00854389_m1

LASS4

155606

1.78E-05

9.02

Downregulated

Hs00226114_m1

STARD10

115998

4.26E-05

6.03

Downregulated

Hs00246405_m1

CSRP2

137165

0.0003

5.7

Downregulated

Hs00426717_m1

RNPC1

215065

0.0003

4.87

Downregulated

Hs00246405_m1

ARFRP1

118657

0.0003

4.85

Downregulated

Hs00182389_m1

ESM1

174810

0.005

4.68

Downregulated

Hs00199831_m1

CASK

143978

0.00035

4.42

Downregulated

Hs00177620_m1

WASF1

118398

0.0001

4.32

Downregulated

Hs00187514_m1

PVRL2

128369

0.0002

4.23

Downregulated

Hs00161054_m1

MGAT4B

186405

0.0002

4.13

Downregulated

Hs00365001_m1

LGALS3BP

185853

9.49E-05

4.12

Downregulated

Hs00174774_m1

PERP

141176

0.0004

3.52

Downregulated

Hs00751717_m1

PGM2L1

138177

0.0005

3.04

Downregulated

Hs00328100_m1

IFNGR1

190183

0.0003

2.57

Downregulated

Hs00166223_m1

USF2

144617

0.0005

1.94

Downregulated

Hs00231528_m1